Javelin Pharmaceuticals (JAV) Receives Notice from Hospira, Inc. (HSP) of Funding of Loan  
6/7/2010 10:37:06 AM

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Javelin Pharmaceuticals, Inc. (NYSE -- Amex: JAV) ("Javelin") today announced that on June 4, 2010, Javelin received notice from Hospira, Inc. ("Hospira") that Hospira will fund a $2 million loan to Javelin on June 10, 2010 under the existing loan agreement between Javelin and Hospira.